Evidence map›Paper›PMID 29087211›Full record

ReviewAmerican journal of respiratory and critical care medicine2018

Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Colleen S Curran, Thomas Bolig, Parizad Torabi-Parizi

Open access · greenAbstract readReview
In one paragraph

Review in American journal of respiratory and critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 177 citations in OpenAlex.

  1. Raphani Semen Extract Targets theFood science & nutrition · 2026
    Article
  2. Genomic diversity ofMicrobial genomics · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Colleen S CurranCritical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland.
Thomas BoligCritical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland.
Parizad Torabi-PariziCritical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland.
National Institutes of Health Clinical Center · US

Funding

Modulation of Host Immunity with Dietary Supplements Nicotinamide and Indole-3-carbinolZIACL090049 · CLC · CLINICAL CENTER · PI TORABI-PARIZI, PARIZAD · 2017 to 2022
$0k
6 · The paper itself

Abstract

Pseudomonas aeruginosa is a complex gram-negative facultative anaerobe replete with a variety of arsenals to activate, modify, and destroy host defense mechanisms. The microbe is a common cause of nosocomial infections and an antibiotic-resistant priority pathogen. In the lung, P. aeruginosa disrupts upper and lower airway homeostasis by damaging the epithelium and evading innate and adaptive immune responses. The biology of these interactions is essential to understand P. aeruginosa pathogenesis. P. aeruginosa interacts directly with host cells via flagella, pili, lipoproteins, lipopolysaccharides, and the type III secretion system localized in the outer membrane. P. aeruginosa quorum-sensing molecules regulate the release of soluble factors that enhance the spread of infection. These characteristics of P. aeruginosa differentially affect lung epithelial, innate, and adaptive immune cells involved in the production of mediators and the recruitment of additional immune cell subsets. Pathogen interactions with individual host cells and in the context of host acute lung infection are discussed to reveal pathways that may be targeted therapeutically.

Indexed as

Cross InfectionHumansLungLung DiseasesPseudomonas aeruginosaPseudomonas InfectionsimmunologyPseudomonas aeruginosaquorum sensingtherapeuticstype III secretion system

Identifiers

PMID29087211
PMCPMC5855068
OpenAlexW2766761875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.